SCHEMBL878658

SCHEMBL878658

CCC(=O)c1ccccc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.64
CTSD P07339 1/20 0.59
ALDH1A1 P00352 1/20 0.57
HTT P42858 1/20 0.57
KMT2A Q03164 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
CTNNB1 P35222 2/20 0.55
WNT3A P56704 2/20 0.55
IDO1 P14902 1/20 0.55
TDO2 P48775 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC1 Q13547 1/20 0.55
HMGCR P04035 1/20 0.55
RAB9A P51151 2/20 0.53
LMNA P02545 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HPGD P15428 2/20 0.51
STAT3 P40763 1/20 0.51
TP53 P04637 1/20 0.51
GLA P06280 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29738645 1.00 NPC1 (0.64) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL21128714 0.86 NPC1 (0.83) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL29987209 0.86 NPC1 (0.83) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL15979734 0.86 CTNNB1 (0.71) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL28812389 0.86 ABCB1 (0.55) NPC1ALDH1A1HTTKMT2AL3MBTL1
SCHEMBL5045736 0.85 NPC1 (0.49) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL30660944 0.85 CTNNB1 (0.61) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL5307918 0.85 CTNNB1 (0.61) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL3702934 0.84 NPC1 (0.64) NPC1CTSDALDH1A1HTTKMT2A
SCHEMBL1448202 0.84 NPC1 (0.64) NPC1CTSDALDH1A1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114858944-B Method for detecting p-methoxypropiophenone related substances 石家庄四药有限公司 2023-02-03 CN claimed
CN-114858944-A Method for detecting p-methoxypropiophenone related substances 石家庄四药有限公司 2022-08-05 CN claimed
CN-114685256-A Preparation method of o-methoxy propiophenone 杭州国瑞生物科技有限公司 2022-07-01 CN claimed
CN-114685290-A Preparation method of methoxyphenamine hydrochloride 杭州国瑞生物科技有限公司 2022-07-01 CN claimed
CN-213160168-U Device for treating waste gas of production workshop of acryloylnaphthyl methyl ether 江苏八巨药业有限公司 2021-05-11 CN claimed
CN-110004162-B Carbonyl reductase, gene and application of carbonyl reductase in methoxamine hydrochloride key intermediate 长兴制药股份有限公司 2021-01-01 CN claimed
CN-101824030-A Preparation method of Iloperidone BEIJING DVENTUREPHARM TECHNOLOGY DEV CO LTD 2010-09-08 CN claimed
CN-1906200-A Novel compounds ASTRAZENECA AB (SE) 2007-01-31 CN claimed
CN-1092653-C (4-piperidnyl)-1H-2-benzopyran derivatives useful as antipsychotic agents AVENTIS PHARMA INC (US) 2002-10-16 CN claimed
CN-1246859-A (4-piperidnyl)-1H-2-benzopyran derivatives useful as antipsychotic agents HOECHST MARION ROUSSEL INC (US) 2000-03-08 CN claimed
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2026-04-09 US disclosed
EP-4676920-A1 PHOTOLABILE CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED DELIVERY OF ACTIVE ALDEHYDES AND KETONES Firmenich SA (CH) 2026-01-14 EP disclosed
EP-4489592-B1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2025-12-24 EP disclosed
EP-4426684-B1 CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES FIRMENICH & CIE (CH) 2025-09-17 EP disclosed
US-20250255827-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-08-14 US disclosed
EP-0115203-B1 BENZHYDRYLPIPERAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Richter Gedeon Vegyészeti Gyár R.T. (HU) 1987-04-01 EP disclosed
EP-0048136-B1 PROCESS FOR PREPARING ALPHA-AROMATIC GROUP SUBSTITUTED ALKANOIC ACIDS OR ESTERS THEREOF SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1986-06-11 EP disclosed
US-4504481-A ENZYME INHIBITORS IN LIVER TO REDUCE TOXIC EFFECT OF DRUGS RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1985-03-12 US disclosed
EP-0115203-A1 Benzhydrylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them Richter Gedeon Vegyészeti Gyár R.T. (HU) 1984-08-08 EP disclosed
US-4225734-A Process for producing symmetrical olefins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1980-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION PCTP, CLK4, MTCL3 NPC1 4362/4885CTSD 605/4885ALDH1A1 4813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.